企業(yè)體檢
成都伊諾達博醫(yī)藥科技有限公司
We are offering three key services for new drug application,
a. Mature(repeatable) pilot process with independent intellectual property rights;
b. High purity sample designed for pharm companies;
c. Impurity study.
Our main products are Ulipristal acetate intermediates &impurities; Alogliptin benzoate intermediates, impurities &metabolin; Ezetimibe intermediates &impurities; Abiraterone Acetate; Dienogest; Tenofovir disoproxil fumarate & its intermediates; Bortezomib; Cabazitaxel; Lacosamide intermediates; Minodronic acid.
| 公司成立時間 |
2007/12/4 0:00:00 |
注冊資本 |
1500萬元人民幣 |
| 經(jīng)營范圍 |
研發(fā)、生產(chǎn)、銷售：醫(yī)藥中間體，化學(xué)藥品、生物藥品的技術(shù)開發(fā)及轉(zhuǎn)讓，化工產(chǎn)品的銷售，其它無需審批或許可的合法項目。
查看產(chǎn)品目錄 |
| 公司地址 |
1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone, |
| 經(jīng)營模式 |
工廠 |
主營行業(yè) |
醫(yī)藥中間體,原料藥 |